Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease
JAMA Neurology Author Interviews - Un podcast de JAMA Network - Les lundis
Interview with John Sims, author of Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials
